CImbinator: a web-based tool for drug synergy analysis in small- and large-scale datasets
Open Access
- 19 March 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 33 (15) , 2410-2412
Abstract
Drug synergies are sought to identify combinations of drugs particularly beneficial. User-friendly software solutions that can assist analysis of large-scale datasets are required. CImbinator is a web-service that can aid in batch-wise and in-depth analyzes of data from small-scale and large-scale drug combination screens. CImbinator offers to quantify drug combination effects, using both the commonly employed median effect equation, as well as advanced experimental mathematical models describing dose response relationships. CImbinator is written in Ruby and R. It uses the R package drc for advanced drug response modeling. CImbinator is available at http://cimbinator.bioinfo.cnio.es, the source-code is open and available at https://github.com/Rbbt-Workflows/combination_index. A Docker image is also available at https://hub.docker.com/r/mikisvaz/rbbt-ci_mbinator/. Supplementary data are available at Bioinformatics online.Keywords
This publication has 10 references indexed in Scilit:
- Combenefit: an interactive platform for the analysis and visualization of drug combinationsBioinformatics, 2016
- Systematic Mapping of Kinase Addiction Combinations in Breast Cancer Cells by Integrating Drug Sensitivity and Selectivity ProfilesChemistry & Biology, 2015
- Patient-derived models of acquired resistance can identify effective drug combinations for cancerScience, 2014
- High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cellsProceedings of the National Academy of Sciences, 2014
- Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug TargetsScience Signaling, 2013
- Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanismsOncotarget, 2013
- The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibitionBritish Journal of Cancer, 2012
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay MethodCancer Research, 2010
- The search for synergy: a critical review from a response surface perspective.Pharmacological Reviews, 1995
- The problem of synergism and antagonism of combined drugs.1953